News + Filings Transactions Holdings
All 13F 13D/G Other
|
Xmark Opportunity Partners, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/14/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/22/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
02/14/2011 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 0.4% stake in NOVELOS THERAPEUTICS, INC. |
12/10/2010 |
SC 13G
| Xmark Opportunity Partners, LLC reports a 7.6% stake in NOVELOS THERAPEUTICS, INC. |
09/08/2010 |
SC 13D/A
| AEOLUS PHARMACEUTICALS, INC. reports a 70.2% stake in Aeolus Pharmaceuticals, Inc. |
02/16/2010 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 0% stake in VIA PHARMACEUTICALS, INC. |
02/16/2010 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 1.6% stake in Advanced Life Sciences Holdings, Inc. |
01/28/2010 |
SC 13D/A
| Xmark Opportunity Partners, LLC reports a 67.4% stake in AEOLUS PHARMACEUTICALS, INC. |
01/26/2010 |
SC 13D/A
| ICAGEN INC reports a 4.4% stake in ICAGEN, INC. |
11/30/2009 |
SC 13D/A
| ICAGEN INC reports a 7% stake in ICAGEN, INC. |
09/09/2009 |
SC 13D/A
| Xmark Opportunity Partners, LLC reports a 8.1% stake in ICAGEN, INC. |
06/18/2009 |
SC 13G
| Xmark Opportunity Partners, LLC reports a 16.3% stake in Genaera Corporation |
04/30/2009 |
SC 13D/A
| Xmark Opportunity Partners, LLC reports a 58.1% stake in AEOLUS PHARMACEUTICALS, INC. |
04/29/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
02/17/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
02/17/2009 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 0% stake in ALLIANCE PHARMACEUTICAL CORP. |
02/17/2009 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 6.8% stake in ADVANCED LIFE SCIENCES HOLDINGS, INC. |
01/15/2009 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
|
|